The Most Advanced Country in Biomedical Engineering
The biotechnology global market size was estimated at $1.38 trillion in 2023 and is expected to reach around $4.25 trillion by 2033 while growing at a CAGR of 11.8%.
Moderna Inc. (MRNA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Theleme Partners Patrick Degorce | 7,226,861 | $858,189,744 | -2% | 41.17% |
| 2. | 1,814,500 | $215,471,875 | -16% | 0.04% | |
| 3. | 1,788,000 | $212,325,000 | -2% | 0.04% | |
| 4. | 1,300,000 | $154,375,000 | 0.72% | ||
| 5. | ARK Investment Management Catherine D. Wood | 1,054,094 | $125,173,672 | -14% | 1.11% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.00 | 52,631 | Director | 420,407 | 2020-02-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $84.10 | 254 | Officer | 1,442,357 | 2024-08-12 | Filing | |
| $121.62 | 1,309 | 2,224,015 | 2024-07-31 | Filing | ||
| $120.88 | 3,428 | 2,225,324 | 2024-07-31 | Filing | ||
| $119.84 | 5,664 | 2,228,752 | 2024-07-31 | Filing | ||
| $118.96 | 4,599 | 2,234,416 | 2024-07-31 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 45,654,527 | $4,540,342,711 | 3.74% | |
| 2. | 33,907,072 | $3,372,058,312 | 0.07% | |
| 3. | 25,301,692 | $2,516,253,271 | 0.06% | |
| 4. | 14,623,723 | $1,454,329,252 | 0.07% | |
| 5. | 9,666,038 | $961,287,479 | 72.53% |
News See All
Moderna, Inc. (NASDAQ:MRNA) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Moderna second quarter 2024 conference call. At this time, all participants are in listen-only mode.
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease.
9 Best Gene Therapy Stocks to Buy Now
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and understand the reasons behind...
Jim Cramer's 10 Stock Picks Heading Into June
Jim Cramer in a latest program lamented over Salesforce's latest declines following the company's weak Q1 results and guidance cut.
Jim Cramer's Latest Stock Picks in May 2024
Jim Cramer on Friday analyzed the market rally following the latest CPI data which showed inflation was easing in April.
Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Moderna, Inc. beats earnings expectations. Reported EPS is $-3.07, expectations were $-3.56.
5 Cathie Wood Stocks Insiders are Selling
Moderna Inc (NASDAQ:MRNA) ranks fifth in our list of the stocks in Cathie Wood's portfolio seeing insider selling.
5 Biggest Biotechnology Companies in the World
Argenx SE (NASDAQ:ARGX), based in the Netherlands, is one of the biggest biotechnology companies in the world known for its innovative immunology solutions.
Billionaire Hedge Funds
